Management guidelines for use of alemtuzumab in B-cell chronic lymphocytic leukemia.
Keating M, Coutré S, Rai K, Osterborg A, Faderl S, Kennedy B, Kipps T, Bodey G, Byrd JC, Rosen S, Dearden C, Dyer MJ, Hillmen P.
Keating M, et al. Among authors: hillmen p.
Clin Lymphoma. 2004 Mar;4(4):220-7. doi: 10.3816/clm.2004.n.002.
Clin Lymphoma. 2004.
PMID: 15072613